Skip to content

Clinical trials

Completed Lung Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Taiwan Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20073
20083
20093
20106
20114
20123
20134
20142
20157
20165
20172
20184
20192
20204
20216
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital8
Novartis Pharmaceuticals8
AstraZeneca4
Chang Gung Memorial Hospital4
Pfizer3
Arcus Biosciences, Inc.2
Boehringer Ingelheim2
Bristol-Myers Squibb2
Incyte Corporation2
Taipei Veterans General Hospital, Taiwan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms68
Carcinoma, Non-Small-Cell Lung37
Neoplasms9
Adenocarcinoma of Lung5
Carcinoma5
Neoplasm Metastasis5
Adenocarcinoma4
Breast Neoplasms4
Colorectal Neoplasms4
Respiratory Tract Diseases4

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.